Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
1.47M
-
Shares change
-
+174K
-
Total reported value, excl. options
-
$1.94M
-
Value change
-
+$222K
-
Number of buys
-
7
-
Number of sells
-
-1
-
Price
-
$1.30
Significant Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q1 2020
14 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q1 2020.
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.47M shares
of 75.5M outstanding shares and own 1.94% of the company stock.
Largest 10 shareholders include BOXER CAPITAL, LLC (920K shares), RENAISSANCE TECHNOLOGIES LLC (232K shares), SPHERA FUNDS MANAGEMENT LTD. (87.5K shares), FNY Investment Advisers, LLC (69.6K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (55.9K shares), Game Plan Financial Advisors, LLC (39.6K shares), VANGUARD GROUP INC (16.8K shares), MORGAN STANLEY (12.2K shares), CITADEL ADVISORS LLC (12.2K shares), and PNC Financial Services Group, Inc. (10K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.